Jing Li, PhD, Robert Tyler Braun, PhD, Sophia Kakarala, and Holly G. Prigerson, PhD
For dying patients and their loved ones to make informed decisions, physicians must share adequate information about prognoses, prospective benefits and harms of specific interventions, and costs.
AMA J Ethics. 2022; 24(11):E1040-1048. doi:
10.1001/amajethics.2022.1040.
Fragmentation in US health care delivery streams and shortcomings in formal quality measures mean that transparency could be more useful to policymakers and regulators than patients.
AMA J Ethics. 2022; 24(11):E1075-1082. doi:
10.1001/amajethics.2022.1075.
Sarosh Nagar, Leah Z. Rand, PhD, and Aaron S. Kesselheim, MD, JD, MPH
This article analyzes differences in prescription drug pricing transparency practices among 3 Organisation of Economic Co-operation and Development member nations.
AMA J Ethics. 2022; 24(11):E1083-1090. doi:
10.1001/amajethics.2022.1083.
Dr Kimberly A. Singletary joins Ethics Talk to discuss her article, coauthored with Dr Marshall H. Chin: “What Should Antiracist Payment Reform Look Like?”
This month, AMA Journal of Ethics theme editor Colleen Farrell, a fourth-year medical student at Harvard Medical School, interviewed Lachlan Forrow, MD, about the benefits of interprofessional collaboration and the importance of biopsychosocial approaches to patient care.
This month, AMA Journal of Ethics theme editor Margaret Cocks, MD, PhD, a third-year resident at Johns Hopkins Hospital, interviewed Theonia Boyd, MD, about ethical issues pathologists face when conducting autopsies and obtaining specimens.